Additional file 5: of Nilotinib (Tasignaâ ˘) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Detailed output for the 666 gene signature in improvers from Fig. 4b . For each gene in the improver gene signature, the following information is provided: where it is upregulated (baseline or post treatment), gene symbol, gene name, raw p value, false discovery rate (FDR)(BH), q value, fold change, baseline mean expression value and post-treatment mean expression value. (XLSX 73 kb)